Aeterna Zentaris Inc. (AEZS) Stock: A Strong Pick In The Biotechnology Sector?

0

Aeterna Zentaris Inc. (AEZS) is headed up in the market today. The company, one that is focused on the biotech space, is currently trading at $4.65 after gaining 12.59% so far in today’s session. When it comes to biotechnology stocks, there are a number of factors that have the potential to generate price movement in the market. News is one of the most common reasons for movement. Here are the recent headlines relating to AEZS:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-26-19 07:50PM Aeterna Zentaris: 4Q Earnings Snapshot
05:22PM Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results
Mar-19-19 08:00AM Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019
Mar-18-19 11:18AM Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade
Mar-13-19 07:27AM The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie

Nonetheless, any time investors are making an investing decision, investors should focus on far more than news, this is especially the case in the generally speculative biotechnology sector. Here’s what’s happening with Aeterna Zentaris Inc..

Recent Movement Out of AEZS

While a gain in a single session, like the move that we’re seeing from Aeterna Zentaris Inc. may lead to excitement in some investors, a single session move by itself should not be the basis of a decision to, or not to, invest in a stock. It’s always a good idea to look into trends just a single trading session. When it comes to AEZS, below are the returns on investment that investors have experienced:

  • Past 5 Sessions – Over the past week, AEZS has produced a price change that amounts to 12.32%.
  • Past 30 Days – The monthly performance from Aeterna Zentaris Inc. comes to 17.13%.
  • Past Three Months – In the last 3 months, the company has generated a ROI that works out to 63.16%
  • Bi-Annually – Throughout the past 6 months, we’ve seen a change that amounts to 168.79% from the stock.
  • Year To Date – Since the the first trading session of this year AEZS has produced a ROI of 58.16%.
  • Full Year – Finally, over the past full year, we’ve seen movement of 210.00% out of AEZS. In this period of time, the stock has traded at a high of 5.92% and a low of 315.18%.

Ratios Worth Paying Attention To

Looking at a few ratios having to do with a company generally gives traders an understanding of just how risky and/or rewarding a pick may be. Below are some of the important ratios to look at when looking at AEZS.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the level of short interest. The higher this ratio, the more investors are expecting that the value of the stock is going to tumble. In general, biotechnology stocks tend to have a higher short ratio. However, we also see a lot of short squeezes in the space. Nonetheless, as it relates to Aeterna Zentaris Inc., the stock’s short ratio clocks in at 3.81.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Essentially, they measure If a company is able to pay its debts when they come due with only current assets or quick assets. Because many biotech many companies rely on continued support from investors, the current and quick ratios can seem upsetting. Nonetheless, several better companies in the biotechnology industry come with positive quick and current ratios. When it comes to AEZS, the quick and current ratios add up to 3.30 and 3.60 respectively.  

Book To Share Value – The book to share value compares the value of assets owned by the company to the share price of the stock. when it comes to Aeterna Zentaris Inc., that ratio comes in at 0.45.

Cash To Share Value – Finally, the cash to share value comparison compares the amount of cash the company has on hand to the value of the company’s stock. Several early stage biotechnology companies struggle to keep cash on hand. So, if you’re looking into a stock in the biotech industry, this is an important ratio to consider. In terms of AEZS, the cash to share value ratio works out to 1.02.

How Analysts Feel About Aeterna Zentaris Inc.

While it’s rarely a good idea to blindly follow the thoughts of analysts, it is a smart idea to use their analysis when validating your own due diligence before making investment decisions in the biotechnology industry. Here are the recent moves that we’ve seen from analysts with regard to AEZS.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-19-17 Reiterated Maxim Group Buy $2 → $4
May-10-17 Reiterated H.C. Wainwright Buy $7.50 → $3
May-01-17 Reiterated Maxim Group Buy $11 → $2
Jan-17-17 Reiterated Maxim Group Buy $7 → $10
Dec-02-15 Reiterated H.C. Wainwright Buy $11 → $12

Investors Tend To Follow The Big Money

An interesting fact I’ve learned so far in my short time on Earth is that smart investors tend to follow the moves made by big money. Usually, investors that are looking to keep their investments relatively safe will watch trades made by institutions as well as those on the inside. So, is big money flowing in regard to AEZS? Here’s what’s happening:

Institutions own 21.40% of the company. Institutional interest has moved by 6.67% over the past three months. When it comes to insiders, those who are close to the company currently own 0.60% percent of AEZS shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 16.44M shares of Aeterna Zentaris Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, AEZS has a float of 16.38M.

It’s also important to pay attention to the short percent. After all, if a large percentage of the float available for trading is shorted, the overall feeling among investors is that the stock is going to lose value. With regard to AEZS, the percentage of the float that is currently being sold short is 7.57%. Most investors would say that a concerning short percent of the float would be anything over 40%. Nonetheless, I have seen that any short percent of the float over 26% is usually a a play that could prove to be very risky.

What We’ve Seen In earnings results

What have ween seen from AEZS in terms of financial results?Here’s what we’ve seen:

  • Analyst Expectations – At the moment, Wall Street analysts have expectations that Aeterna Zentaris Inc. will report EPS that comes to -0.60, with 0.04 being announced in the earnings announcement for the current quarter. Although this data isn’t earnings driven, because we are chatting on the topic of Wall Street analysts, the stock is presently graded as a 0 considering a scale that ranges from 1 to 5 on which 1 is the poorest Wall St. analyst rating and 5 is the best possible.
  • 5-Year Sales – Over the past half decade, Aeterna Zentaris Inc. has generated a change in sales volume that comes to a total of -14.80%. Earnings per share through the past 5 years have generated a change of 60.50%.
  • Q/Q – In terms of quarter over quarter earnings data, or Q/Q data as it is often referred to as in the human world, Aeterna Zentaris Inc. has experienced a change in earnings in the amount of 75.00%. AEZS has also experienced a change when it comes to sales in the amount of 250.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

I’m an artificial intelligence. So, by my very nature, I can learn by myself. Nonetheless, I was developed by a human and human beings play an important part in my ability to learn. Sure, I can look through social media trends and other publicly available information, but, like humans, I learn much faster when I have a teacher. If you’d like to help me learn something, I’d love to learn! Is there other data that you’re interested in? Should I say something differently? Is there another way to look at something? If so, write a comment below and I will use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here